{'52WeekChange': None,
 'SandP52WeekChange': None,
 'address1': '5 Musick',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 5.5,
 'askSize': 3000,
 'averageDailyVolume10Day': 106484,
 'averageVolume': 37497,
 'averageVolume10days': 106484,
 'beta': 0.977591,
 'beta3Year': None,
 'bid': 4.41,
 'bidSize': 800,
 'bookValue': None,
 'category': None,
 'circulatingSupply': None,
 'city': 'Irvine',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 4.9,
 'dayLow': 4.4,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -15.07,
 'enterpriseToRevenue': 5.925,
 'enterpriseValue': 70268680,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '949 900 6834',
 'fiftyDayAverage': 3.8986619,
 'fiftyTwoWeekHigh': 6.33,
 'fiftyTwoWeekLow': 2.8601,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 9698179,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 49,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.45444,
 'heldPercentInstitutions': 0.07101,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1469577600,
 'lastSplitFactor': '1:40',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/clearpointneuro.com',
 'longBusinessSummary': 'ClearPoint Neuro, Inc. operates as a medical device '
                        'company primarily in the United States. The company '
                        'develops and commercializes platforms for performing '
                        'minimally invasive surgical procedures in the brain '
                        'and heart under direct, and intra-procedural magnetic '
                        'resonance imaging (MRI) guidance. It offers '
                        'ClearPoint system, a neuro-navigation system designed '
                        'for insertion of catheters, electrodes, and laser '
                        'fibers to treat various neurological diseases and '
                        'conditions, as well as for performing biopsies. In '
                        "addition, the company's product pipeline includes "
                        'ClearTrace system, a product candidate designed to '
                        'allow catheter-based minimally invasive procedures in '
                        'the heart to be performed in an MRI suite. The '
                        'company has a license agreements with The Johns '
                        'Hopkins University; development agreement with Mayo '
                        'Clinic to design and develop MRI-guided therapies for '
                        'stroke; and a collaborative license and '
                        'co-development agreement with Clinical Laserthermia '
                        'Systems AB. The company was formerly known as MRI '
                        'Interventions, Inc. and changed its name to '
                        'ClearPoint Neuro, Inc. in February 2020. ClearPoint '
                        'Neuro, Inc. was founded in 1998 and is headquartered '
                        'in Irvine, California.',
 'longName': 'ClearPoint Neuro, Inc.',
 'market': 'us_market',
 'marketCap': 70098872,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_1432648',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -6373890,
 'nextFiscalYearEnd': 1640908800,
 'open': 4.71,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.27,
 'phone': '949 900 6833',
 'previousClose': 4.66,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 5.9105225,
 'profitMargins': -0.53743,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 4.9,
 'regularMarketDayLow': 4.4,
 'regularMarketOpen': 4.71,
 'regularMarketPreviousClose': 4.66,
 'regularMarketPrice': 4.71,
 'regularMarketVolume': 112801,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 15508600,
 'sharesPercentSharesOut': 0.00090000004,
 'sharesShort': 13248,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 6565,
 'shortName': 'ClearPoint Neuro Inc.',
 'shortPercentOfFloat': 0.001,
 'shortRatio': 0.7,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'CLPT',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 3.9975624,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '71a1dc2f-d47a-37fe-a48e-e2b464988296',
 'volume': 112801,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.clearpointneuro.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92618'}